These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1092887)

  • 41. [Inhalation devices].
    Zellweger JP
    Schweiz Rundsch Med Prax; 1993 May; 82(19):565-9. PubMed ID: 8506435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M; Lamont H; Pauwels R; Tasson J
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparison of the effect of aerosol inhalation with Salbutamol and Trimetolquinol of four and a half minutes duration with that of Tacholiquin-Orciprenalin of fifteen minutes duration in bronchial asthma].
    Scherrer M; Bachofen H
    Schweiz Med Wochenschr; 1972 Jul; 102(26):909-14. PubMed ID: 4556145
    [No Abstract]   [Full Text] [Related]  

  • 44. [Inhalation therapy--advantages and difficulties].
    Karrer W
    Praxis (Bern 1994); 1997 Dec; 86(50):1975-8. PubMed ID: 9465723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaler and spacer use in obstructive airway diseases.
    Jones MD; Yeager H
    Am Fam Physician; 1990 Oct; 42(4):1007-13. PubMed ID: 2220509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Postoperative respiratory therapy: bronchospasmolytic activity and side-effects of some recently introduced beta-sympatheticomimetic agents (author's transl)].
    Brandl M; Beer S; Hamer P
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):197-202. PubMed ID: 7027819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Does halothane, in subnarcotic dosage, have a detectable broncholytic effect?].
    Gerking A; Ebert C; Precht B; Paliege R; Kirsten D; Pielesch W
    Z Erkr Atmungsorgane; 1986; 166(2):180-5. PubMed ID: 3716494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance.
    Bäcklund L; Fagerberg E
    Scand J Respir Dis; 1968; 49(4):284-90. PubMed ID: 5194717
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of obstructive respiratory tract diseases. Staging therapy according to severity].
    Ulmer WT
    Fortschr Med; 1992 Nov; 110(32):607-8. PubMed ID: 1478599
    [No Abstract]   [Full Text] [Related]  

  • 50. [Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease].
    Ringbaek TJ; Phanareth K; Lange P
    Ugeskr Laeger; 1996 Oct; 158(42):5957-62. PubMed ID: 8928288
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative clinical study of KWD 2019, terbutaline, and adrenaline administered subcutaneously to respiratory insufficiency patients].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1971; 62(2):192-203. PubMed ID: 5112904
    [No Abstract]   [Full Text] [Related]  

  • 52. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease.
    Hahn DL
    N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868
    [No Abstract]   [Full Text] [Related]  

  • 53. Nebuliser therapy.
    Esmond G
    Prof Nurse; 1998 Oct; 14(1):39-43. PubMed ID: 9866617
    [No Abstract]   [Full Text] [Related]  

  • 54. Geriatrics for the clinician. Inhalation therapy and the elderly: what every physician should consider.
    Tsoukleris MG; Michocki RJ
    Md Med J; 1995 Dec; 44(12):1049-52. PubMed ID: 8544672
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019).
    Mattila MJ; Muittari A
    Ann Med Exp Biol Fenn; 1969; 47(4):298-302. PubMed ID: 4911261
    [No Abstract]   [Full Text] [Related]  

  • 56. [Broncholytic inhalation therapy. Double-blind study hexoprenaline orziprenaline in chronic obstructive respiratory tract diseases].
    Debelić M
    Schweiz Med Wochenschr; 1974 Sep; 104(38):1321-6. PubMed ID: 4608626
    [No Abstract]   [Full Text] [Related]  

  • 57. Humidification and mist therapy in chronic obstructive lung disease.
    Holley HS
    Int Anesthesiol Clin; 1970; 8(3):617-35. PubMed ID: 5286189
    [No Abstract]   [Full Text] [Related]  

  • 58. [Obstructive respiratory tract diseases. Diagnosis and principles of therapy].
    Heinl KW
    Med Monatsschr Pharm; 1989 Nov; 12(11):338-43. PubMed ID: 2685525
    [No Abstract]   [Full Text] [Related]  

  • 59. [The influence of orciprenaline on the regional relationships between ventilation and perfusion in irreversible bronchial obstruction].
    Stiksa J; Daum S; Nikodýmová L
    Arzneimittelforschung; 1967 May; 17(5):568-72. PubMed ID: 5631586
    [No Abstract]   [Full Text] [Related]  

  • 60. On the effects of aerosol bronchodilator and some problems of ultrasonic nebulization--its pharmacological potency with or without positive pressure.
    Goto Y; Harada J; Sugiura Y
    Z Erkr Atmungsorgane; 1986; 166(1):107-9. PubMed ID: 2869611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.